CENCORA, INC. (COR) Free cash flow
- Free cash flow · 12 months (USD): Value $4.06B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 1.22%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $4.06B | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $4.82B − $760.85M ≈ $4.06B |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 1.22% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $4.06B ÷ $332.77B × 100 ≈ 1.22% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $4.82B | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.84× | Operating cash flow / net income. Period ending 2026-06-30. $4.82B ÷ $2.62B ≈ 1.84× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 4.82B USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 760.85M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 4.06B USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 332.77B USD | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 2.62B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.06B | (m) | $4.82B | $760.85M | (m) | $332.77B | (m) | $2.62B | (m) | (m) | 1.22% | 1.84× |
| 2026-03-31 | $1.56B | (m) | $2.28B | $718.02M | (m) | $328.68B | (m) | $2.55B | (m) | (m) | 0.47% | 0.89× |
| 2025-12-31 | $3.61B | (m) | $4.29B | $681.46M | (m) | $325.78B | (m) | $1.63B | (m) | (m) | 1.11% | 2.64× |
| 2025-09-30 | $3.21B | (m) | $3.88B | $667.98M | (m) | $321.33B | (m) | $1.55B | (m) | (m) | 1.00% | 2.49× |
| 2025-06-30 | $1.14B | (m) | $1.74B | $600.49M | (m) | $316.65B | (m) | $1.90B | (m) | (m) | 0.36% | 0.92× |
| 2025-03-31 | $3.58B | (m) | $4.11B | $535.16M | (m) | $310.23B | (m) | $1.69B | (m) | (m) | 1.15% | 2.43× |
| 2024-12-31 | $-638.10M | (m) | $-119.25M | $518.85M | (m) | $303.19B | (m) | $1.40B | (m) | (m) | -0.21% | -0.09× |
| 2024-09-30 | $3.00B | (m) | $3.48B | $487.17M | (m) | $293.96B | (m) | $1.51B | (m) | (m) | 1.02% | 2.31× |
| 2024-06-30 | $3.83B | (m) | $4.31B | $480.35M | (m) | $283.83B | (m) | $1.86B | (m) | (m) | 1.35% | 2.32× |
| 2024-03-31 | $2.11B | (m) | $2.58B | $466.75M | (m) | $276.54B | (m) | $1.85B | (m) | (m) | 0.76% | 1.39× |
| 2023-12-31 | $3.63B | (m) | $4.09B | $456.85M | (m) | $271.58B | (m) | $1.87B | (m) | (m) | 1.34% | 2.19× |
| 2023-09-30 | $3.45B | (m) | $3.91B | $458.36M | (m) | $262.17B | (m) | $1.75B | (m) | (m) | 1.32% | 2.24× |
| 2023-06-30 | $2.79B | (m) | $3.25B | $456.45M | (m) | $254.43B | (m) | $1.69B | (m) | (m) | 1.10% | 1.92× |
| 2023-03-31 | $2.45B | (m) | $2.91B | $465.56M | (m) | $247.54B | (m) | $1.62B | (m) | (m) | 0.99% | 1.80× |
| 2022-12-31 | $2.06B | (m) | $2.55B | $492.35M | (m) | $241.81B | (m) | $1.73B | (m) | (m) | 0.85% | 1.47× |
| 2022-09-30 | $2.21B | (m) | $2.70B | $496.32M | (m) | $238.59B | (m) | $1.70B | (m) | (m) | 0.92% | 1.59× |
| 2022-06-30 | $2.06B | (m) | $2.55B | $487.54M | (m) | $236.33B | (m) | $1.84B | (m) | (m) | 0.87% | 1.38× |
| 2022-03-31 | $2.85B | (m) | $3.35B | $495.95M | (m) | $229.67B | (m) | $1.73B | (m) | (m) | 1.24% | 1.94× |
| 2021-12-31 | $2.17B | (m) | $2.63B | $452.50M | (m) | $221.10B | (m) | $1.61B | (m) | (m) | 0.98% | 1.63× |
| 2021-09-30 | $2.23B | (m) | $2.67B | $438.22M | (m) | $213.99B | (m) | $1.54B | (m) | (m) | 1.04% | 1.73× |
| 2021-06-30 | $2.56B | (m) | $2.96B | $391.98M | (m) | $204.32B | (m) | $-3.74B | (m) | (m) | 1.25% | -0.79× |
| 2021-03-31 | $1.28B | (m) | $1.66B | $376.91M | (m) | $196.28B | (m) | $-3.75B | (m) | (m) | 0.65% | -0.44× |
| 2020-12-31 | $2.60B | (m) | $2.97B | $367.78M | (m) | $194.55B | (m) | $-3.22B | (m) | (m) | 1.34% | -0.92× |
| 2020-09-30 | $1.84B | (m) | $2.21B | $369.68M | (m) | $189.89B | (m) | $-3.41B | (m) | (m) | 0.97% | -0.65× |
| 2020-06-30 | $1.25B | (m) | $1.58B | $330.56M | (m) | $186.29B | (m) | $1.57B | (m) | (m) | 0.67% | 1.01× |
| 2020-03-31 | $1.94B | (m) | $2.24B | $293.12M | (m) | $186.16B | (m) | $1.58B | (m) | (m) | 1.04% | 1.41× |
| 2019-12-31 | $1.71B | (m) | $2.01B | $298.29M | (m) | $182.06B | (m) | $649.35M | (m) | (m) | 0.94% | 3.09× |
| 2019-09-30 | $2.03B | (m) | $2.34B | $310.22M | (m) | $179.59B | (m) | $855.37M | (m) | (m) | 1.13% | 2.74× |
| 2019-06-30 | $2.02B | (m) | $2.34B | $318.82M | (m) | $177.25B | (m) | $956.03M | (m) | (m) | 1.14% | 2.44× |
| 2019-03-31 | $2.26B | (m) | $2.59B | $329.08M | (m) | $175.15B | (m) | $929.88M | (m) | (m) | 1.29% | 2.79× |
| 2018-12-31 | $1.54B | (m) | $1.88B | $342.00M | (m) | $172.87B | (m) | $1.19B | (m) | (m) | 0.89% | 1.58× |
| 2018-09-30 | $1.07B | (m) | $1.41B | $336.41M | (m) | $167.94B | (m) | $1.66B | (m) | (m) | 0.64% | 0.85× |
| 2018-06-30 | $1.78B | (m) | $2.13B | $343.33M | (m) | $163.76B | (m) | $1.08B | (m) | (m) | 1.09% | 1.97× |
| 2018-03-31 | $686.00M | (m) | $1.06B | $372.51M | (m) | $159.33B | (m) | $855.07M | (m) | (m) | 0.43% | 1.24× |
| 2017-12-31 | $1.54B | (m) | $1.94B | $402.76M | (m) | $155.44B | (m) | $979.09M | (m) | (m) | 0.99% | 1.99× |
| 2017-09-30 | $1.04B | (m) | $1.50B | $466.40M | (m) | $153.14B | (m) | $364.48M | (m) | (m) | 0.68% | 4.13× |
| 2017-06-30 | $952.34M | (m) | $1.48B | $525.87M | (m) | $151.58B | (m) | $854.76M | (m) | (m) | 0.63% | 1.73× |
| 2017-03-31 | $1.37B | (m) | $1.91B | $547.30M | (m) | $149.76B | (m) | $1.15B | (m) | (m) | 0.91% | 1.66× |
| 2016-12-31 | $1.48B | (m) | $2.00B | $511.79M | (m) | $148.31B | (m) | $1.35B | (m) | (m) | 1.00% | 1.48× |
| 2016-09-30 | $2.71B | (m) | $3.18B | $464.62M | (m) | $146.85B | (m) | $1.43B | (m) | (m) | 1.85% | 2.23× |
| 2016-06-30 | $2.60B | (m) | $2.98B | $384.67M | (m) | $144.76B | (m) | $1.65B | (m) | (m) | 1.79% | 1.81× |
| 2016-03-31 | $3.61B | (m) | $3.91B | $306.40M | (m) | $142.11B | (m) | $1.51B | (m) | (m) | 2.54% | 2.59× |
| 2015-12-31 | $3.51B | (m) | $3.77B | $269.14M | (m) | $139.08B | (m) | $395.44M | (m) | (m) | 2.52% | 9.54× |
| 2015-09-30 | $3.69B | (m) | $3.92B | $231.59M | (m) | $135.96B | (m) | $-134.89M | (m) | (m) | 2.71% | -29.06× |
| 2015-06-30 | $3.37B | (m) | $3.59B | $222.88M | (m) | $132.08B | (m) | $-431.37M | (m) | (m) | 2.55% | -8.32× |
| 2015-03-31 | $2.74B | (m) | $2.99B | $244.27M | (m) | $128.19B | (m) | $-658.32M | (m) | (m) | 2.14% | -4.54× |
| 2014-12-31 | $3.11B | (m) | $3.36B | $257.83M | (m) | $123.98B | (m) | $35.15M | (m) | (m) | 2.51% | 95.69× |
| 2014-09-30 | $1.20B | (m) | $1.46B | $264.46M | (m) | $119.57B | (m) | $276.48M | (m) | (m) | 1.00% | 5.29× |
| 2014-06-30 | $338.36M | (m) | $601.56M | $263.19M | (m) | $112.45B | (m) | $259.70M | (m) | (m) | 0.30% | 2.32× |
| 2014-03-31 | $-82.34M | (m) | $157.12M | $239.47M | (m) | $104.01B | (m) | $440.92M | (m) | (m) | -0.08% | 0.36× |
| 2013-12-31 | $-179.16M | (m) | $26.19M | $205.35M | (m) | $96.08B | (m) | $306.48M | (m) | (m) | -0.19% | 0.09× |
| 2013-09-30 | $585.67M | (m) | $788.13M | $202.45M | (m) | $87.96B | (m) | $433.71M | (m) | (m) | 0.67% | 1.82× |
| 2013-06-30 | $1.19B | (m) | $1.36B | $178.34M | (m) | $82.55B | (m) | $546.18M | (m) | (m) | 1.44% | 2.50× |
| 2013-03-31 | $1.19B | (m) | $1.38B | $188.94M | (m) | $81.38B | (m) | $559.01M | (m) | (m) | 1.46% | 2.47× |
| 2012-12-31 | $456.99M | (m) | $632.04M | $175.05M | (m) | $80.64B | (m) | $725.48M | (m) | (m) | 0.57% | 0.87× |
| 2012-09-30 | $1.14B | (m) | $1.31B | $164.04M | (m) | $79.49B | (m) | $718.99M | (m) | (m) | 1.44% | 1.82× |
| 2012-06-30 | $952.07M | (m) | $1.12B | $168.08M | (m) | $80.61B | (m) | $702.82M | (m) | (m) | 1.18% | 1.59× |
| 2012-03-31 | $1.10B | (m) | $1.26B | $162.38M | (m) | $81.00B | (m) | $705.96M | (m) | (m) | 1.35% | 1.78× |
| 2011-12-31 | $1.53B | (m) | $1.70B | $166.00M | (m) | $80.69B | (m) | $708.24M | (m) | (m) | 1.90% | 2.40× |
| 2011-09-30 | $999.99M | (m) | $1.17B | $167.95M | (m) | $80.22B | (m) | $706.62M | (m) | (m) | 1.25% | 1.65× |
| 2011-06-30 | $1.18B | (m) | $1.36B | $179.81M | (m) | $79.53B | (m) | $700.53M | (m) | (m) | 1.48% | 1.94× |
| 2011-03-31 | $1.15B | (m) | $1.34B | $190.37M | (m) | $78.97B | (m) | $679.31M | (m) | (m) | 1.46% | 1.97× |
| 2010-12-31 | $858.96M | (m) | $1.05B | $192.15M | (m) | $78.51B | (m) | $645.94M | (m) | (m) | 1.09% | 1.63× |
| 2010-09-30 | $923.99M | (m) | $1.11B | $184.63M | (m) | $77.95B | (m) | $636.75M | (m) | (m) | 1.19% | 1.74× |
| 2010-06-30 | $736.78M | (m) | $912.70M | $175.92M | (m) | $76.95B | (m) | $625.67M | (m) | (m) | 0.96% | 1.46× |
| 2010-03-31 | $932.45M | (m) | $1.10B | $165.29M | (m) | $75.75B | (m) | $581.27M | (m) | (m) | 1.23% | 1.89× |
| 2009-12-31 | $900.37M | (m) | $1.05B | $146.07M | (m) | $73.76B | (m) | $543.65M | (m) | (m) | 1.22% | 1.92× |
| 2009-09-30 | $637.93M | (m) | $783.76M | $145.84M | (m) | $71.76B | (m) | $503.40M | (m) | (m) | 0.89% | 1.56× |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | $599.76M | (m) | $737.07M | $137.31M | (m) | $70.19B | (m) | $250.56M | (m) | (m) | 0.85% | 2.94× |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-09-30 | $1.10B | (m) | $1.21B | $111.28M | (m) | $65.67B | (m) | $469.17M | (m) | (m) | 1.67% | 2.57× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |